Clinical Trial Update: A Study of XZB-0004 in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of XZB-0004 in patients with solid tumors, including non-small cell lung cancer, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• XZB-0004

Snippet

Sponsor: Xuanzhu Biopharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumor, NSCLC | Phase 1 | Status: RECRUITING